ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,400, issued on June 23, was assigned to Scholar Rock Inc. (Cambridge, Mass.).
"Methods of treating myopathies with anti-pro/latent myostatin antibodies" was invented by Michelle Straub (Yarmouth, Maine), Dong Yun Lee (Boston), William K. McConaughy (Boston), Katherine Jane Turner (Acton, Mass.), Nagesh K. Mahanthappa (Cambridge, Mass.) and Justin W. Jackson (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the present disclosure relate to antibodies that specifically bind proMyostatin and/or latent Myostatin and uses thereof."
The patent was filed on Feb. 2, 2024, under Application No. 18/431,294.
*For further information...